Healthcare packaging solutions provider Clondalkin Group has entered into a strategic partnership with Spain-based print manufacturer Pharma Prospect to develop and enhance its pharma and healthcare business throughout Europe.
The group hopes that the partnership will strengthen its credibilty and demonstrate to customers that it aims to become a leading global packaging supplier.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Clondalkin sales and marketing director Malcolm Farnan said that Pharma Prospect provides print solutions to pharmaceutical, medical device, healthcare and cosmetic industries.
"Like us, they focus on providing innovative, value added packaging solutions and developing strong and long-lasting customer relationships," said Farnan.
"By working together and effectively promoting each other’s skills and expertise, the agreement will enable both parties to realise new opportunities and strengthen our growth strategies in Europe."
The strategic partnership with Clondalkin is expected to help Pharma Prospect to operate in the Spanish pharmaceutical market.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataPharma Prospect produces a range of printed paper leaflets and also provides design, pre-press, supply chain management and packaging system services.
Clondalkin Group’s pharma and healthcare division supplies cartons, labels and literature through a network of 17 accredited sites across North America and Europe.
